Business Description
Circio Holding ASA
ISIN : NO0013033795
Compare
Compare
Traded in other countries / regions
CRNA.NorwayTA50.Germany0RIS.UKTRVXO.Sweden IPO Date
2016-07-08Description
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients. The company's pipeline candidate includes circVec and Mutant KRAS.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | -5.77 | |||||
| Debt-to-Equity | -0.81 | |||||
| Debt-to-EBITDA | 2.85 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -23.5 | |||||
| Beneish M-Score | -7.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -57.8 | |||||
| 3-Year EBITDA Growth Rate | 26.4 | |||||
| 3-Year EPS without NRI Growth Rate | 27 | |||||
| 3-Year FCF Growth Rate | 32.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.78 | |||||
| 9-Day RSI | 46.89 | |||||
| 14-Day RSI | 47.26 | |||||
| 6-1 Month Momentum % | -82.61 | |||||
| 12-1 Month Momentum % | -74.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.06 | |||||
| Days Sales Outstanding | 16848.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.4 | |||||
| Shareholder Yield % | 24.64 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -41293.5 | |||||
| Net Margin % | 7730.08 | |||||
| FCF Margin % | -40022.76 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 33.34 | |||||
| ROIC % | -67.6 | |||||
| ROC (Joel Greenblatt) % | 366.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.08 | |||||
| Forward PE Ratio | 0.05 | |||||
| PE Ratio without NRI | 1.08 | |||||
| PEG Ratio | 0.02 | |||||
| PS Ratio | 49.88 | |||||
| EV-to-EBIT | 5.71 | |||||
| EV-to-EBITDA | 5.34 | |||||
| EV-to-Revenue | 533.79 | |||||
| EV-to-FCF | -1.31 | |||||
| Earnings Yield (Greenblatt) % | 17.51 | |||||
| FCF Yield % | -146.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Circio Holding ASA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.123 | ||
| EPS (TTM) (kr) | 0.737 | ||
| Beta | 1.6 | ||
| Volatility % | 112.9 | ||
| 14-Day RSI | 47.26 | ||
| 14-Day ATR (kr) | 0.233757 | ||
| 20-Day SMA (kr) | 0.861 | ||
| 12-1 Month Momentum % | -74.89 | ||
| 52-Week Range (kr) | 0.54 - 13.029038 | ||
| Shares Outstanding (Mil) | 41.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Circio Holding ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Circio Holding ASA Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Circio Holding ASA Frequently Asked Questions
What is Circio Holding ASA(OSL:CRNA)'s stock price today?
The current price of OSL:CRNA is kr0.80. The 52 week high of OSL:CRNA is kr13.03 and 52 week low is kr0.54.
When is next earnings date of Circio Holding ASA(OSL:CRNA)?
The next earnings date of Circio Holding ASA(OSL:CRNA) is 2025-02-14 Est..
Does Circio Holding ASA(OSL:CRNA) pay dividends? If so, how much?
Circio Holding ASA(OSL:CRNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers